CALYTRIX BIO
Live / Applied — Non-final action mailed (as of 16 Dec 2025)
What this means for you
Not registered yet, but its 01 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99314648
- Mark type
- Stylized text
- Filed
- 01 Aug 2025
- Attorney of record
- Michael Graif
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of myeloproliferative neoplasms and other hematologic diseases
- Class 042 — Scientific and technological services: Pharmaceutical research in the field of hematology and oncology
Owner
- JLSA Therapeutics Inc., Wellesley, MA, US
Prosecution history
- 16 Mar 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 16 Mar 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 16 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Dec 2025 — NON-FINAL ACTION E-MAILED
- 16 Dec 2025 — NON-FINAL ACTION WRITTEN
- 16 Dec 2025 — ASSIGNED TO EXAMINER
- 09 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 01 Aug 2025 — NEW APPLICATION ENTERED